The conduct of cancer clinical research in the United States is supported by both private and public sponsors. Industry aims to obtain new drug approvals. Federally sponsored trials examine a broad ...

Kaizen-led utilization improvement at medical oncology daycare unit.

Quality intervention to facilitate clinician-patient discussions of lung cancer biomarker testing at safety net and non safety net centers. Rates of influenza vaccination by PDSA cycle.

In 2012, the National Academies of Sciences, Engineering, and Medicine convened a committee charged with addressing the quality of cancer care in the United States and providing recommendations to ...

Primary Results of NRG-RTOG1106/ECOG-ACRIN 6697: A Randomized Phase II Trial of Individualized Adaptive (chemo)Radiotherapy Using Midtreatment 18F-Fluorodeoxyglucose ...

When You Get to the Fork in the Road, Take It: The Challenges in Managing Patients With Advanced Prostate Cancer A multi-institution retrospective study of patients with mTNBC treated with SG from ...

This commentary explores the intergenerational (affecting and involving multiple generations) harm caused by cancer and cancer-related deaths in African countries, particularly cancer and ...

Oncoplastic Breast-Conserving Surgery in African Women: A Systematic Review Jordan, a lower- to middle-income country, is relatively small, but with rapidly growing population and a challenged economy ...

Understanding the impact of historical redlining on prostate cancer care quality and treatment patterns and the association with modern metrics of disparity. Time interval for new patients to acquire ...

Long-Term Risk of Subsequent Neoplasms in 5-Year Survivors of Childhood Neuroblastoma: A Dutch Childhood Cancer Survivor Study-LATER 3 Study In the article that accompanies this editorial, Sun et al 9 ...

Survival Outcomes Associated With First-Line Procarbazine, CCNU, and Vincristine or Temozolomide in Combination With Radiotherapy in IDH-Mutant 1p/19q-Codeleted Grade 3 Oligodendroglioma Using pooled ...

The ideas and opinions expressed in these Data Supplements do not necessarily reflect those of the American Society of Clinical Oncology (ASCO). The mention of any product, service, or therapy in ...